Vimarsana
Biggest News Aggregation in the World

Page 2 - Acticor Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acticor Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acticor Biotech Today - Breaking & Trending Today

Acticor Biotech Announces Its Financial Calendar for the 1st Half of 2024 - Vimarsana News

Acticor Biotech Announces Its Financial Calendar for the 1st Half of 2024

25.01.2024 - Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announced today its financial agenda for the 1st half of ...

Acticor Biotech continues to soar, hopes for stroke treatment - Vimarsana News

Acticor Biotech continues to soar, hopes for stroke treatment

Acticor Biotech's share price continued to soar on the Paris Bourse on Wednesday, the day after the biopharmaceutical company presented positive results for stroke treatment.At 4.30pm, the share price...

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023 - Vimarsana News

ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of December 31, 2023

17.01.2024 - Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, today discloses the total number of voting ...

Acticor: capital increase at a significant discount -November 28, 2023 at 05:44 am EST - Vimarsana News

Acticor: capital increase at a significant discount -November 28, 2023 at 05:44 am EST

On Tuesday, Acticor Biotech announced its intention to launch a capital increase of around 2.6 million euros at a significant discount to the stock market price.The biotech company plans to issue...

ACTICOR BIOTECH: Participation of Acticor Biotech to the 15th World Stroke Congress 2023 - Vimarsana News

ACTICOR BIOTECH: Participation of Acticor Biotech to the 15th World Stroke Congress 2023

Presentation of the latest results on glenzocimab in Stroke patientsPARIS--(BUSINESS WIRE)--Regulatory News:ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, announced to...